GUIDANCE DOCUMENT
Labeling OTC Human Drug Products Using a Column Format December 2000
- Docket Number:
- FDA-1999-D-1300
- Issued by:
-
Guidance Issuing OfficeCenter for Drug Evaluation and Research
This guidance is intended to assist manufacturers, packers, and distributors who wish to present labeling information for their over-the-counter (OTC) human drug products using a column format.
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-1999-D-1300.